Veterinary Medicines

Fevaxyn Pentofel (--) - Suspension for injection

Not authorised
  • Feline leukemia virus, Strain AH 927/1161E, Inactivated
  • Felid herpesvirus 1, strain 605, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Chlamydia felis, strain Cello, Inactivated
  • Feline panleucopenia virus, strain CU4, Inactivated
Download as PDF

Product identification

Medicine name:
Fevaxyn Pentofel (--) - Suspension for injection
Active substance:
  • Feline leukemia virus, Strain AH 927/1161E, Inactivated
  • Felid herpesvirus 1, strain 605, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Chlamydia felis, strain Cello, Inactivated
  • Feline panleucopenia virus, strain CU4, Inactivated
Target species:
This information is not available for this product.
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline leukemia virus, Strain AH 927/1161E, Inactivated
    Presentation_strength:≥ 1.45 RP Reference:Hse Index:0
  • Felid herpesvirus 1, strain 605, Inactivated
    1.60
    relative potency
    /
    1.00
    Syringe
  • Feline calicivirus, strain 255, Inactivated
    1.65
    relative potency
    /
    1.00
    Syringe
  • Chlamydia felis, strain Cello, Inactivated
    2.00
    relative potency
    /
    1.00
    Syringe
  • Feline panleucopenia virus, strain CU4, Inactivated
    9.50
    relative potency
    /
    1.00
    Syringe
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Zoetis Belgium SA
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 24/10/2024
Download
Bulgarian (PDF)
Published on: 24/10/2024
Download
Croatian (PDF)
Published on: 24/10/2024
Download
Czech (PDF)
Published on: 24/10/2024
Download
Danish (PDF)
Published on: 24/10/2024
Download
Dutch (PDF)
Published on: 24/10/2024
Download
Estonian (PDF)
Published on: 24/10/2024
Download
Finnish (PDF)
Published on: 24/10/2024
Download
French (PDF)
Published on: 24/10/2024
Download
German (PDF)
Published on: 24/10/2024
Download
Greek (PDF)
Published on: 24/10/2024
Download
Hungarian (PDF)
Published on: 24/10/2024
Download
Icelandic (PDF)
Published on: 24/10/2024
Download
Italian (PDF)
Published on: 24/10/2024
Download
Latvian (PDF)
Published on: 24/10/2024
Download
Lithuanian (PDF)
Published on: 24/10/2024
Download
Maltese (PDF)
Published on: 24/10/2024
Download
Norwegian (PDF)
Published on: 24/10/2024
Download
Polish (PDF)
Published on: 24/10/2024
Download
Portuguese (PDF)
Published on: 24/10/2024
Download
Romanian (PDF)
Published on: 24/10/2024
Download
Slovak (PDF)
Published on: 24/10/2024
Download
Slovenian (PDF)
Published on: 24/10/2024
Download
Spanish (PDF)
Published on: 24/10/2024
Download
Swedish (PDF)
Published on: 24/10/2024
Download

ema-puar-v30-fevaxynpentofel-wpar-2024-10-04-en.pdf

English (PDF)
Published on: 24/10/2024
Download

ema-puar-fevaxyn-pentofel-v-030-par-en.pdf

English (PDF)
Published on: 14/03/2023
Download